Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Nuclear Medicine

Free Subscription Articles published in Semin Nucl Med Retrieve available abstracts of 172 articles: HTML format

Single Articles

March 2024
1. VAN DER GEEST KSM, Gheysens O, Gormsen LC, Glaudemans AWJM, et al
   Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends.
   Semin Nucl Med. 2024 Mar 26:S0001-2998(24)00026.
   PubMed     Abstract available
   
   
   
2. HIGUCHI T, Serfling SE, Leistner DM, Speer T, et al
   FAPI-PET in Cardiovascular Disease.
   Semin Nucl Med. 2024 Mar 21:S0001-2998(24)00023.
   PubMed     Abstract available
   
   
   
3. GUJA KE, Ganjoo KN, Iagaru A
   Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
   Semin Nucl Med. 2024 Mar 2:S0001-2998(24)00012.
   PubMed     Abstract available
   
   
   
4. EKMEKCIOGLU O, Albert NL, Heinrich K, Tolboom N, et al
   Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques.
   Semin Nucl Med. 2024;54:237-246.
   PubMed     Abstract available
   
   
   
5. EVANGELISTA L, Israel O
   Letter From the Guest Editors.
   Semin Nucl Med. 2024;54:181-182.
   PubMed    
   
   
   
6. FILIPPI L, Camedda R, Frantellizzi V, Urbano N, et al
   Functional Imaging in Musculoskeletal Disorders in Menopause.
   Semin Nucl Med. 2024;54:206-218.
   PubMed     Abstract available
   
   
   February 2024
7. KHALATBARI H, Shulkin BL, Parisi MT
   PET/CT and PET/MR in Soft Tissue Sarcoma: An Update.
   Semin Nucl Med. 2024 Feb 28:S0001-2998(24)00005.
   PubMed     Abstract available
   
   
   
8. ULANER GA, Vaz SC
   Women's Health Update: Growing Role of PET for Patients with Breast Cancer.
   Semin Nucl Med. 2024 Feb 16:S0001-2998(24)00006.
   PubMed     Abstract available
   
   
   
9. GIAMMARILE F, Knoll P, Paez D, Estrada Lobato E, et al
   Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine.
   Semin Nucl Med. 2024 Feb 15:S0001-2998(24)00001.
   PubMed     Abstract available
   
   
   
10. KHESSIB T, Jha P, Davidzon GA, Iagaru A, et al
    Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
    Semin Nucl Med. 2024 Feb 10:S0001-2998(24)00003.
    PubMed     Abstract available
    
    
    
11. EISAZADEH R, Shahbazi-Akbari M, Mirshahvalad SA, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers Part II. [(18)F]F-FLT, [(18)F]F-FET, [(11)C]C-MET and Other Less-Commonly Used Radiotracers.
    Semin Nucl Med. 2024 Feb 7:S0001-2998(24)00002.
    PubMed     Abstract available
    
    
    January 2024
12. EVANGELISTA L, Guglielmo P, Pietrzak A, Lazar AM, et al
    The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health.
    Semin Nucl Med. 2024 Jan 12:S0001-2998(23)00105.
    PubMed     Abstract available
    
    
    
13. ZAMANI-SIAHKALI N, Mirshahvalad SA, Farbod A, Divband G, et al
    SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases.
    Semin Nucl Med. 2024 Jan 2:S0001-2998(23)00093.
    PubMed     Abstract available
    
    
    December 2023
14. BENTESTUEN M, Nalliah S, Stolberg MMK, Zacho HD, et al
    How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers.
    Semin Nucl Med. 2023 Dec 4:S0001-2998(23)00092.
    PubMed     Abstract available
    
    
    
15. TELLI T, Desaulniers M, Pyka T, Caobelli F, et al
    What Role Does PET/MRI Play in Musculoskeletal Disorders?
    Semin Nucl Med. 2023 Dec 2:S0001-2998(23)00091.
    PubMed     Abstract available
    
    
    November 2023
16. GHEYSENS O, de Ponfilly MP, Nocturne G, Seror R, et al
    [(18)F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects.
    Semin Nucl Med. 2023 Nov 28:S0001-2998(23)00083.
    PubMed     Abstract available
    
    
    
17. MOKOALA KMG, Ndlovu H, Lawal I, Sathekge MM, et al
    PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions.
    Semin Nucl Med. 2023 Nov 27:S0001-2998(23)00087.
    PubMed     Abstract available
    
    
    
18. BRINK A, Israel O, Nadel H, Arevalo-Pardo M, et al
    Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce.
    Semin Nucl Med. 2023 Nov 18:S0001-2998(23)00086.
    PubMed     Abstract available
    
    
    
19. VOTER AF, Werner RA, Savas H, Gafita A, et al
    A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
    Semin Nucl Med. 2023 Nov 16:S0001-2998(23)00088.
    PubMed     Abstract available
    
    
    
20. BESSON FL, Nocturne G, Noel N, Gheysens O, et al
    PET/CT in Inflammatory and Auto-immune Disorders: Focus on Several Key Molecular Concepts, FDG, and Radiolabeled Probe Perspectives.
    Semin Nucl Med. 2023 Nov 14:S0001-2998(23)00084.
    PubMed     Abstract available
    
    
    
21. CARACCIOLO M, Castello A, Lopci E
    PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview.
    Semin Nucl Med. 2023 Nov 9:S0001-2998(23)00082.
    PubMed     Abstract available
    
    
    
22. GIUBBINI R, Paghera B, Dondi M, Estrada Lobato E, et al
    Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.
    Semin Nucl Med. 2023;53:733-742.
    PubMed     Abstract available
    
    
    
23. LOW CS, Rao N
    Imaging of Gastrointestinal Bleeding: An Update.
    Semin Nucl Med. 2023;53:766-776.
    PubMed     Abstract available
    
    
    
24. SIRAJ QH
    Functional Imaging of Testicular Torsion.
    Semin Nucl Med. 2023;53:797-808.
    PubMed     Abstract available
    
    
    
25. LE ROUX PY, Le Pennec R, Salaun PY, Zuckier LS, et al
    Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices.
    Semin Nucl Med. 2023;53:743-751.
    PubMed     Abstract available
    
    
    
26. JABBARPOUR A, Ghassel S, Lang J, Leung E, et al
    The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review.
    Semin Nucl Med. 2023;53:752-765.
    PubMed     Abstract available
    
    
    
27. LINDENBERG L, Ahlman M, Lin F, Mena E, et al
    Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor.
    Semin Nucl Med. 2023 Nov 1:S0001-2998(23)00080.
    PubMed     Abstract available
    
    
    September 2023
28. MIRSHAHVALAD SA, Eisazadeh R, Shahbazi-Akbari M, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers.
    Semin Nucl Med. 2023 Sep 24:S0001-2998(23)00073.
    PubMed     Abstract available
    
    
    
29. NEKOLLA SG, Rischpler C, Higuchi T
    Preclinical Imaging of Cardiovascular Disesase.
    Semin Nucl Med. 2023;53:586-598.
    PubMed     Abstract available
    
    
    
30. CURRIE GM
    Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?
    Semin Nucl Med. 2023;53:719-730.
    PubMed     Abstract available
    
    
    
31. KUPER A, Blanc-Durand P, Gafita A, Kersting D, et al
    Is There a Role of Artificial Intelligence in Preclinical Imaging?
    Semin Nucl Med. 2023;53:687-693.
    PubMed     Abstract available
    
    
    
32. OLKOWSKI C, Fernandes B, Griffiths GL, Lin F, et al
    Preclinical Imaging of Prostate Cancer.
    Semin Nucl Med. 2023;53:644-662.
    PubMed     Abstract available
    
    
    
33. ALSTRUP AKO, Dollerup MR, Simonsen MIT, Vendelbo MH, et al
    Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care.
    Semin Nucl Med. 2023;53:570-576.
    PubMed     Abstract available
    
    
    August 2023
34. GAMMEL MCM, Solari EL, Eiber M, Rauscher I, et al
    A Clinical Role of PET-MRI in Prostate Cancer ?
    Semin Nucl Med. 2023 Aug 29:S0001-2998(23)00069.
    PubMed     Abstract available
    
    
    
35. SLART RHJA, Martinez-Lucio TS, Boersma HH, Borra RH, et al
    [(15)O]H(2)O PET: Potential or Essential for Molecular Imaging?
    Semin Nucl Med. 2023 Aug 26:S0001-2998(23)00070.
    PubMed     Abstract available
    
    
    
36. LAUDICELLA R, Bauckneht M, Burger IA
    Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?
    Semin Nucl Med. 2023 Aug 18:S0001-2998(23)00060.
    PubMed     Abstract available
    
    
    
37. MOHSENINIA N, Zamani-Siahkali N, Harsini S, Divband G, et al
    Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging.
    Semin Nucl Med. 2023 Aug 16:S0001-2998(23)00057.
    PubMed     Abstract available
    
    
    
38. SEIFERT R, Gafita A, Telli T, Voter A, et al
    Standardized PSMA-PET Imaging of Advanced Prostate Cancer.
    Semin Nucl Med. 2023 Aug 10:S0001-2998(23)00059.
    PubMed     Abstract available
    
    
    
39. DUAN H, Iagaru A
    PSMA PET for Detection of Recurrence.
    Semin Nucl Med. 2023 Aug 9:S0001-2998(23)00056.
    PubMed     Abstract available
    
    
    
40. SWIHA M, Ayati N, Oprea-Lager DE, Ceci F, et al
    How to Report PSMA PET.
    Semin Nucl Med. 2023 Aug 7:S0001-2998(23)00068.
    PubMed     Abstract available
    
    
    July 2023
41. JOCHUMSEN MR, Bouchelouche K
    PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview.
    Semin Nucl Med. 2023 Jul 22:S0001-2998(23)00055.
    PubMed     Abstract available
    
    
    
42. LAWAL IO, Ndlovu H, Kgatle M, Mokoala KMG, et al
    Prognostic Value of PSMA PET/CT in Prostate Cancer.
    Semin Nucl Med. 2023 Jul 22:S0001-2998(23)00058.
    PubMed     Abstract available
    
    
    
43. ALATI S, Singh R, Pomper MG, Rowe SP, et al
    Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer.
    Semin Nucl Med. 2023 Jul 17:S0001-2998(23)00053.
    PubMed     Abstract available
    
    
    
44. ALSTRUP AKO, Busk M, Dittrich A, Hansen K, et al
    Special Challenges in PET Imaging of Ectothermic Vertebrates.
    Semin Nucl Med. 2023 Jul 10:S0001-2998(23)00052.
    PubMed     Abstract available
    
    
    
45. GILLETT D, MacFarlane J, Bashari W, Crawford R, et al
    Molecular Imaging of Pituitary Tumors.
    Semin Nucl Med. 2023;53:530-538.
    PubMed     Abstract available
    
    
    
46. LALONDE MN, Correia RD, Syktiotis GP, Schaefer N, et al
    Parathyroid Imaging.
    Semin Nucl Med. 2023;53:490-502.
    PubMed     Abstract available
    
    
    
47. BUSCOMBE J
    Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer.
    Semin Nucl Med. 2023;53:475-480.
    PubMed     Abstract available
    
    
    
48. FENG L, Li S, Wang C, Yang J, et al
    Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma.
    Semin Nucl Med. 2023;53:517-529.
    PubMed     Abstract available
    
    
    
49. FORTUNATI E, Bonazzi N, Zanoni L, Fanti S, et al
    Molecular imaging Theranostics of Neuroendocrine Tumors.
    Semin Nucl Med. 2023;53:539-554.
    PubMed     Abstract available
    
    
    
50. SUTHERLAND DEK, Azad AA, Murphy DG, Eapen RS, et al
    Role of FDG PET/CT in Management of Patients with Prostate Cancer.
    Semin Nucl Med. 2023 Jul 1:S0001-2998(23)00051.
    PubMed     Abstract available
    
    
    June 2023
51. VETRONE L, Fortunati E, Castellucci P, Fanti S, et al
    Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?
    Semin Nucl Med. 2023 Jun 30:S0001-2998(23)00047.
    PubMed     Abstract available
    
    
    
52. LINDGREN BELAL S, Frantz S, Minarik D, Enqvist O, et al
    Applications of Artificial Intelligence in PSMA PET/CT for Prostate Cancer Imaging.
    Semin Nucl Med. 2023 Jun 23:S0001-2998(23)00049.
    PubMed     Abstract available
    
    
    
53. HARTRAMPF PE, Serfling SE, Michalski K, Buck AK, et al
    PSMA PET/CT for Response Assessment of (177)Lu-PSMA Therapy.
    Semin Nucl Med. 2023 Jun 23:S0001-2998(23)00050.
    PubMed     Abstract available
    
    
    
54. FILIPPI L, Urso L, Schillaci O, Evangelista L, et al
    Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?
    Semin Nucl Med. 2023 Jun 1:S0001-2998(23)00038.
    PubMed     Abstract available
    
    
    May 2023
55. BUSK M, Sinning S, Alstrup AKO, Munk OL, et al
    Nuclear Medicine Preclinical Research: The Role of Cell Cultures.
    Semin Nucl Med. 2023 May 31:S0001-2998(23)00035.
    PubMed     Abstract available
    
    
    
56. VAN LEER B, van Rijsewijk ND, Nijsten MWN, Slart RHJA, et al
    Practice of (18)F-FDG-PET/CT in ICU Patients: A Systematic Review.
    Semin Nucl Med. 2023 May 29:S0001-2998(23)00039.
    PubMed     Abstract available
    
    
    
57. HIGUCHI T, Hartrampf PE, Buck AK, Pomper MG, et al
    Role of Functional SPECT and PET in Renal Emergencies.
    Semin Nucl Med. 2023 May 24:S0001-2998(23)00031.
    PubMed     Abstract available
    
    
    
58. CHIN J, Vali R, Charron M, Shammas A, et al
    Update on Pediatric Nuclear Medicine in Acute Care.
    Semin Nucl Med. 2023 May 19:S0001-2998(23)00034.
    PubMed    
    
    
    
59. COOLS R, Kerkhofs K, Leitao RCF, Bormans G, et al
    Preclinical Evaluation of Novel PET Probes for Dementia.
    Semin Nucl Med. 2023 May 4:S0001-2998(23)00028.
    PubMed     Abstract available
    
    
    
60. INTENZO C, Miller J, Gulati A, Colarossi D, et al
    The Role of Nuclear Medicine in Benign Thyroid Disease.
    Semin Nucl Med. 2023 May 2:S0001-2998(23)00029.
    PubMed     Abstract available
    
    
    
61. POMYKALA KL, Fendler WP, Vermesh O, Umutlu L, et al
    Molecular Imaging of Lymphoma: Future Directions and Perspectives.
    Semin Nucl Med. 2023;53:449-456.
    PubMed     Abstract available
    
    
    April 2023
62. KLEYNHANS J, Sathekge MM, Ebenhan T
    Preclinical Research Highlighting Contemporary Targeting Mechanisms of Radiolabelled Compounds for PET Based Infection Imaging.
    Semin Nucl Med. 2023 Apr 1:S0001-2998(23)00025.
    PubMed     Abstract available
    
    
    March 2023
63. JEET V, Parkinson B, Song R, Sharma R, et al
    Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis.
    Semin Nucl Med. 2023 Mar 31:S0001-2998(23)00012.
    PubMed     Abstract available
    
    
    
64. VEZIROGLU EM, Farhadi F, Hasani N, Nikpanah M, et al
    Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma.
    Semin Nucl Med. 2023 Mar 2:S0001-2998(22)00108.
    PubMed     Abstract available
    
    
    
65. REGIS C, Benali K, Rouzet F
    FDG PET/CT Imaging of Sarcoidosis.
    Semin Nucl Med. 2023;53:258-272.
    PubMed     Abstract available
    
    
    
66. FERRO P, Boni R, Slart RH, Erba PA, et al
    Imaging of Endocarditis and Cardiac Device-Related Infections: An Update.
    Semin Nucl Med. 2023;53:184-198.
    PubMed     Abstract available
    
    
    
67. NORIEGA-ALVAREZ E, Martin-Comin J
    Molecular Imaging in Inflammatory Bowel Disease.
    Semin Nucl Med. 2023;53:273-286.
    PubMed     Abstract available
    
    
    
68. GOODMAN AL, Packham A, Sharkey AR, Cook GJR, et al
    Advanced Imaging for Detection of Foci of Infection in Staphylococcus aureus Bacteremia- Can a Scan Save Lives?
    Semin Nucl Med. 2023;53:175-183.
    PubMed     Abstract available
    
    
    
69. PALESTRO CJ
    Molecular Imaging of Periprosthetic Joint Infections.
    Semin Nucl Med. 2023;53:167-174.
    PubMed     Abstract available
    
    
    
70. NAKAHARA T, Strauss HW, Narula J, Jinzaki M, et al
    Vulnerable Plaque Imaging.
    Semin Nucl Med. 2023;53:230-240.
    PubMed     Abstract available
    
    
    
71. JAMAR F, van der Laken CJ, Panagiotidis E, Steinz MM, et al
    Update on Imaging of Inflammatory Arthritis and Related Disorders.
    Semin Nucl Med. 2023;53:287-300.
    PubMed     Abstract available
    
    
    February 2023
72. BENTESTUEN M, Al-Obaydi N, Zacho HD
    FAPI-avid nonmalignant PET/CT findings: An expedited systematic review.
    Semin Nucl Med. 2023 Feb 20:S0001-2998(23)00008.
    PubMed     Abstract available
    
    
    January 2023
73. TREGLIA G, Rufini V, Piccardo A, Imperiale A, et al
    Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine.
    Semin Nucl Med. 2023 Jan 24:S0001-2998(23)00003.
    PubMed     Abstract available
    
    
    
74. ZHANG X, Wakabayashi H, Hiromasa T, Kayano D, et al
    Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma.
    Semin Nucl Med. 2023 Jan 12:S0001-2998(22)00117.
    PubMed     Abstract available
    
    
    
75. SIGNORE A, Bentivoglio V, Varani M, Lauri C, et al
    Current Status of SPECT Radiopharmaceuticals for Specific Bacteria Imaging.
    Semin Nucl Med. 2023 Jan 4:S0001-2998(22)00111.
    PubMed     Abstract available
    
    
    
76. ELSAKKA A, Yeh R, Das J
    The Clinical Utility of Molecular Imaging in COVID-19: An Update.
    Semin Nucl Med. 2023;53:98-106.
    PubMed     Abstract available
    
    
    
77. ARNON-SHELEG E, Keidar Z
    Vascular Graft Infection Imaging.
    Semin Nucl Med. 2023;53:70-77.
    PubMed     Abstract available
    
    
    
78. VAN RIJSEWIJK ND, IJpma FFA, Wouthuyzen-Bakker M, Glaudemans AWJM, et al
    Molecular Imaging of Fever of Unknown Origin: An Update.
    Semin Nucl Med. 2023;53:4-17.
    PubMed     Abstract available
    
    
    
79. LAWAL IO, Abubakar S, Ankrah AO, Sathekge MM, et al
    Molecular Imaging of Tuberculosis.
    Semin Nucl Med. 2023;53:37-56.
    PubMed     Abstract available
    
    
    December 2022
80. ZANONI L, Bezzi D, Nanni C, Paccagnella A, et al
    PET/CT in Non-Hodgkin Lymphoma: An Update.
    Semin Nucl Med. 2022 Dec 13:S0001-2998(22)00096.
    PubMed     Abstract available
    
    
    November 2022
81. BEZZI D, Ambrosini V, Nanni C
    Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update.
    Semin Nucl Med. 2022 Nov 26:S0001-2998(22)00095.
    PubMed     Abstract available
    
    
    
82. ZEMAN MN, Akin EA, Merryman RW, Jacene HA, et al
    Interim FDG-PET/CT for Response Assessment of Lymphoma.
    Semin Nucl Med. 2022 Nov 11. pii: S0001-2998(22)00092.
    PubMed     Abstract available
    
    
    
83. KIRIENKO M, Erba PA, Chiti A, Sollini M, et al
    Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence.
    Semin Nucl Med. 2022 Nov 8. pii: S0001-2998(22)00093.
    PubMed     Abstract available
    
    
    
84. AL-IBRAHEEM A, Mottaghy FM, Juweid ME
    PET/CT in Hodgkin Lymphoma: An Update.
    Semin Nucl Med. 2022 Nov 8. pii: S0001-2998(22)00091.
    PubMed     Abstract available
    
    
    
85. NOVRUZOV E, Mori Y, Antke C, Dabir M, et al
    A Role of Non-FDG Tracers in Lung Cancer?
    Semin Nucl Med. 2022;52:720-733.
    PubMed     Abstract available
    
    
    
86. EIBSCHUTZ LS, Flors L, Taravat F, Gholamrezanezhad A, et al
    Imaging Approach to Disease of the Pleura.
    Semin Nucl Med. 2022;52:797-805.
    PubMed     Abstract available
    
    
    
87. HICKS RJ
    The Value of the Standardized Uptake Value (SUV) and Metabolic Tumor Volume (MTV) in Lung Cancer.
    Semin Nucl Med. 2022;52:734-744.
    PubMed     Abstract available
    
    
    October 2022
88. KHALATBARI H, Shulkin BL, Parisi MT
    Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity.
    Semin Nucl Med. 2022 Oct 25. pii: S0001-2998(22)00089.
    PubMed     Abstract available
    
    
    
89. RAVAL NR, Wetherill RR, Wiers CE, Dubroff JG, et al
    Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies.
    Semin Nucl Med. 2022 Oct 18. pii: S0001-2998(22)00076.
    PubMed     Abstract available
    
    
    
90. VORSTER M
    Gallium-68 Labelled Radiopharmaceuticals for Imaging Inflammatory Disorders.
    Semin Nucl Med. 2022 Oct 18. pii: S0001-2998(22)00073.
    PubMed     Abstract available
    
    
    
91. PEPPER NB, Oertel M, Rehn S, Kobe C, et al
    Modern PET-guided radiotherapy planning and treatment for malignant lymphoma.
    Semin Nucl Med. 2022 Oct 12. pii: S0001-2998(22)00086.
    PubMed     Abstract available
    
    
    September 2022
92. DE AZEVEDO D, Geers J, Gheysens O, Dweck M, et al
    (18)F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases.
    Semin Nucl Med. 2022 Sep 15. pii: S0001-2998(22)00075.
    PubMed     Abstract available
    
    
    
93. TREGLIA G, Albano D, Dondi F, Bertagna F, et al
    A Role of [(18)F]FDG PET/CT for Response Assessment in Large Vessel Disease?
    Semin Nucl Med. 2022 Sep 5. pii: S0001-2998(22)00070.
    PubMed     Abstract available
    
    
    
94. SAKELLIS CG, Jacene HA
    Imaging for Radiation Planning in Breast Cancer.
    Semin Nucl Med. 2022;52:542-550.
    PubMed     Abstract available
    
    
    
95. ULANER GA
    16alpha-18F-fluoro-17beta-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer.
    Semin Nucl Med. 2022;52:574-583.
    PubMed     Abstract available
    
    
    
96. HATAZAWA J
    The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update.
    Semin Nucl Med. 2022;52:619-627.
    PubMed     Abstract available
    
    
    
97. COOK GJR
    Imaging of Bone Metastases in Breast Cancer.
    Semin Nucl Med. 2022;52:531-541.
    PubMed     Abstract available
    
    
    August 2022
98. LOPCI E, Castello A, Mansi L
    FDG PET/CT for Staging and Restaging Malignant Mesothelioma.
    Semin Nucl Med. 2022 Aug 11. pii: S0001-2998(22)00068.
    PubMed     Abstract available
    
    
    
99. ANKRAH AO, Lawal IO, Dierckx RAJO, Sathekge MM, et al
    Imaging of Invasive Fungal Infections- The Role of PET/CT.
    Semin Nucl Med. 2022 Aug 3. pii: S0001-2998(22)00057.
    PubMed     Abstract available
    
    
    July 2022
100. DENDL K, Koerber SA, Tamburini K, Mori Y, et al
     Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies.
     Semin Nucl Med. 2022 Jul 13. pii: S0001-2998(22)00033.
     PubMed     Abstract available
     
     
     
101. DEJANOVIC D, Specht L, Czyzewska D, Kiil Berthelsen A, et al
     Response Evaluation Following Radiation Therapy With (18)F-FDG PET/CT: Common Variants of Radiation-Induced Changes and Potential Pitfalls.
     Semin Nucl Med. 2022 Jul 11. pii: S0001-2998(22)00055.
     PubMed     Abstract available
     
     
     
102. BRINK A
     Pitfalls of Radionuclide Renal Imaging in Pediatrics.
     Semin Nucl Med. 2022;52:432-444.
     PubMed     Abstract available
     
     
     
103. VOLKAN-SALANCI B, Erbas B
     Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting.
     Semin Nucl Med. 2022;52:445-452.
     PubMed     Abstract available
     
     
     
104. BAR-SEVER Z, Shammas A, Gheisari F, Vali R, et al
     Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy.
     Semin Nucl Med. 2022;52:419-431.
     PubMed     Abstract available
     
     
     June 2022
105. MANAPOV F, Eze C, Holzgreve A, Kasmann L, et al
     PET/CT for Target Delineation of Lung Cancer Before Radiation Therapy.
     Semin Nucl Med. 2022 Jun 30. pii: S0001-2998(22)00053.
     PubMed     Abstract available
     
     
     
106. KRARUP MMK, Fischer BM, Christensen TN
     New PET Tracers: Current Knowledge and Perspectives in Lung Cancer.
     Semin Nucl Med. 2022 Jun 22. pii: S0001-2998(22)00052.
     PubMed     Abstract available
     
     
     
107. KANDATHIL A, Subramaniam RM
     FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma.
     Semin Nucl Med. 2022 Jun 20. pii: S0001-2998(22)00048.
     PubMed     Abstract available
     
     
     
108. MANAFI-FARID R, Askari E, Shiri I, Pirich C, et al
     [(18)F]FDG-PET/CT radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications.
     Semin Nucl Med. 2022 Jun 15. pii: S0001-2998(22)00035.
     PubMed     Abstract available
     
     
     May 2022
109. MARCUS C, Tajmir SH, Rowe SP, Sheikhbahaei S, et al
     (18)F-FDG PET/CT for Response Assessment in Lung Cancer.
     Semin Nucl Med. 2022 May 28. pii: S0001-2998(22)00032.
     PubMed     Abstract available
     
     
     
110. LEGER MA, Routy B, Juneau D
     FDG PET/CT for Evaluation of Immunotherapy Response in Lung Cancer Patients.
     Semin Nucl Med. 2022 May 27. pii: S0001-2998(22)00047.
     PubMed     Abstract available
     
     
     
111. GROHEUX D
     FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer.
     Semin Nucl Med. 2022 May 27. pii: S0001-2998(22)00051.
     PubMed     Abstract available
     
     
     
112. GROOTJANS W, Rietbergen DD, van Velden FH
     Added Value of Respiratory Gating in Positron Emission Tomography for the Clinical Management of Lung Cancer Patients.
     Semin Nucl Med. 2022 May 25. pii: S0001-2998(22)00037.
     PubMed     Abstract available
     
     
     
113. SANDACH P, Seifert R, Fendler WP, Hautzel H, et al
     A Role for PET/CT in response assessment of malignant pleural mesothelioma.
     Semin Nucl Med. 2022 May 24. pii: S0001-2998(22)00039.
     PubMed     Abstract available
     
     
     
114. HILDEBRANDT MG, Naghavi-Behzad M, Vogsen M
     A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
     Semin Nucl Med. 2022 May 4. pii: S0001-2998(22)00029.
     PubMed     Abstract available
     
     
     
115. HANSEN SB, Bender D
     Advancement in Production of Radiotracers.
     Semin Nucl Med. 2022;52:266-275.
     PubMed     Abstract available
     
     
     March 2022
116. PARK EA, Graves SA, Menda Y
     The Impact of Radiopharmaceutical Therapy on Renal Function.
     Semin Nucl Med. 2022 Mar 18. pii: S0001-2998(22)00018.
     PubMed     Abstract available
     
     
     
117. ADLER SS, Seidel J, Choyke PL
     Advances in Preclinical PET.
     Semin Nucl Med. 2022 Mar 17. pii: S0001-2998(22)00016.
     PubMed     Abstract available
     
     
     
118. NG QK, Triumbari EKA, Omidvari N, Cherry SR, et al
     Total-body PET/CT - first clinical experiences and future perspectives.
     Semin Nucl Med. 2022 Mar 7. pii: S0001-2998(22)00002.
     PubMed     Abstract available
     
     
     
119. BRUCKMANN NM, Morawitz J, Fendler WP, Ruckhaberle E, et al
     A Role of PET/MR in Breast Cancer?
     Semin Nucl Med. 2022 Mar 5. pii: S0001-2998(22)00003.
     PubMed     Abstract available
     
     
     
120. POLOMSKI ES, Antoni ML, Jukema JW, Kroep JR, et al
     Nuclear medicine imaging methods of radiation-induced cardiotoxicity.
     Semin Nucl Med. 2022 Mar 1. pii: S0001-2998(22)00013.
     PubMed     Abstract available
     
     
     February 2022
121. RITT P
     Recent Developments in SPECT/CT.
     Semin Nucl Med. 2022 Feb 21. pii: S0001-2998(22)00004.
     PubMed     Abstract available
     
     
     January 2022
122. ZANOTTI-FREGONARA P
     Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals.
     Semin Nucl Med. 2022 Jan 21. pii: S0001-2998(21)00108.
     PubMed     Abstract available
     
     
     
123. WERNER RA, Pomper MG, Buck AK, Rowe SP, et al
     SPECT and PET Radiotracers in Renal Imaging.
     Semin Nucl Med. 2022 Jan 17. pii: S0001-2998(21)00104.
     PubMed     Abstract available
     
     
     
124. MENA E, Lindenberg L, Choyke P
     The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment.
     Semin Nucl Med. 2022 Jan 8. pii: S0001-2998(21)00109.
     PubMed     Abstract available
     
     
     
125. BOUCHELOUCHE K
     PET/CT in Bladder Cancer: An Update.
     Semin Nucl Med. 2022 Jan 4. pii: S0001-2998(21)00105.
     PubMed     Abstract available
     
     
     
126. ZUCKIER LS
     Safe Pulmonary Scintigraphy in the Era of COVID-19.
     Semin Nucl Med. 2022;52:48-55.
     PubMed     Abstract available
     
     
     December 2021
127. SEIFERT R, Kersting D, Rischpler C, Opitz M, et al
     Clinical Use of PET/MR in Oncology: An Update.
     Semin Nucl Med. 2021 Dec 31. pii: S0001-2998(21)00099.
     PubMed     Abstract available
     
     
     
128. BOGDANOVIC B, Solari EL, Villagran Asiares A, McIntosh L, et al
     PET/MR Technology: Advancement and Challenges.
     Semin Nucl Med. 2021 Dec 27. pii: S0001-2998(21)00101.
     PubMed     Abstract available
     
     
     
129. MARENGO M, Martin CJ, Rubow S, Sera T, et al
     Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine.
     Semin Nucl Med. 2021 Dec 13. pii: S0001-2998(21)00093.
     PubMed     Abstract available
     
     
     
130. TREVES ST, Fahey FH
     Radiation Dose to Pediatric Patients From Radiopharmaceuticals.
     Semin Nucl Med. 2021 Dec 13. pii: S0001-2998(21)00094.
     PubMed     Abstract available
     
     
     
131. KENNEDY J, Chicheportiche A, Keidar Z
     Quantitative SPECT/CT for dosimetry of peptide receptor radionuclide therapy.
     Semin Nucl Med. 2021 Dec 12. pii: S0001-2998(21)00091.
     PubMed     Abstract available
     
     
     
132. INOUE Y
     Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography.
     Semin Nucl Med. 2021 Dec 6. pii: S0001-2998(21)00096.
     PubMed     Abstract available
     
     
     
133. FARINA A, Gasperini C, Aparisi Gomez MP, Bazzocchi A, et al
     The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
     Semin Nucl Med. 2021 Dec 6. pii: S0001-2998(21)00076.
     PubMed     Abstract available
     
     
     
134. VINNIKOV V, Belyakov O
     Clinical Applications of Biological Dosimetry in Patients Exposed to Low Dose Radiation Due to Radiological, Imaging or Nuclear Medicine Procedures.
     Semin Nucl Med. 2021 Dec 6. pii: S0001-2998(21)00095.
     PubMed     Abstract available
     
     
     November 2021
135. LOPEZ-MORA DA, Carrio I, Flotats A
     Digital PET vs Analog PET: Clinical Implications?
     Semin Nucl Med. 2021 Nov 23. pii: S0001-2998(21)00080.
     PubMed     Abstract available
     
     
     
136. AIDE N, Lasnon C, Desmonts C, Armstrong IS, et al
     Advances in PET-CT technology: An update.
     Semin Nucl Med. 2021 Nov 22. pii: S0001-2998(21)00081.
     PubMed     Abstract available
     
     
     
137. DIMITRAKOPOULOU-STRAUSS A, Pan L, Sachpekidis C
     Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use.
     Semin Nucl Med. 2021 Nov 19. pii: S0001-2998(21)00077.
     PubMed     Abstract available
     
     
     July 2021
138. PILKINGTON P, Lopci E, Adam JA, Kobe C, et al
     FDG-PET/CT Variants and Pitfalls in Haematological Malignancies.
     Semin Nucl Med. 2021 Jul 13. pii: S0001-2998(21)00046.
     PubMed     Abstract available
     
     
     
139. MEI R, Farolfi A, Castellucci P, Nanni C, et al
     PET/CT variants and pitfalls in prostate cancer: What you might see on PET and should never forget.
     Semin Nucl Med. 2021 Jul 12. pii: S0001-2998(21)00048.
     PubMed     Abstract available
     
     
     
140. DEJANOVIC D, Hansen NL, Loft A
     PET/CT Variants and Pitfalls in Gynecological Cancers.
     Semin Nucl Med. 2021 Jul 9. pii: S0001-2998(21)00038.
     PubMed     Abstract available
     
     
     
141. VAN DE WIELE C, Juanito G, Vander BK, Ismaheel L, et al
     Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients.
     Semin Nucl Med. 2021 Jul 7. pii: S0001-2998(21)00042.
     PubMed     Abstract available
     
     
     
142. PIJL JP, Nienhuis PH, Kwee TC, Glaudemans AWJM, et al
     Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation.
     Semin Nucl Med. 2021 Jul 7. pii: S0001-2998(21)00040.
     PubMed     Abstract available
     
     
     
143. TSAI YJ, Liu C
     Pitfalls on PET/CT Due to Artifacts and Instrumentation.
     Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00047.
     PubMed     Abstract available
     
     
     
144. VASIREDDI A, Nguyen NC
     PET/CT limitations and pitfalls in urogenital cancers.
     Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00045.
     PubMed     Abstract available
     
     
     
145. AGRAWAL A, Shah S, Gnanasegaran G, Rajkotia S, et al
     PET/CT Normal Variants and Pitfalls in Pediatric disorders.
     Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00039.
     PubMed     Abstract available
     
     
     
146. BENZ MR, Crompton JG, Harder D
     PET/CT variants and pitfalls in bone and soft tissue sarcoma.
     Semin Nucl Med. 2021 Jul 5. pii: S0001-2998(21)00041.
     PubMed     Abstract available
     
     
     
147. KIRIENKO M, Telo S, Hustinx R, Bomanji JB, et al
     The Impact of COVID-19 on Nuclear Medicine in Europe.
     Semin Nucl Med. 2021 Jul 1. pii: S0001-2998(21)00054.
     PubMed     Abstract available
     
     
     
148. VOLKAN-SALANCI B, Erbas B
     Imaging in Renal Transplants: An Update.
     Semin Nucl Med. 2021;51:364-379.
     PubMed     Abstract available
     
     
     
149. CLEMMENSEN TS, Jensen NM, Eiskjaer H
     Imaging of Cardiac Transplantation: An Overview.
     Semin Nucl Med. 2021;51:335-348.
     PubMed     Abstract available
     
     
     
150. CHEN W, Dilsizian V
     Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections.
     Semin Nucl Med. 2021;51:357-363.
     PubMed     Abstract available
     
     
     June 2021
151. MILLS RA, Thompson RC
     Cardiac PET and SPECT During the COVID-19 Pandemic.
     Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00052.
     PubMed     Abstract available
     
     
     
152. EIBSCHUTZ LS, Rabiee B, Asadollahi S, Gupta A, et al
     FDG-PET/CT of COVID-19 and Other Lung Infections.
     Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00049.
     PubMed     Abstract available
     
     
     
153. GIAMMARILE F, Delgado Bolton RC, El-Haj N, Mikhail M, et al
     Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America.
     Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00050.
     PubMed     Abstract available
     
     
     
154. PAEZ D, Mikhail-Lette M, Gnanasegaran G, Dondi M, et al
     Nuclear Medicine Departments in the Era of COVID-19.
     Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00051.
     PubMed     Abstract available
     
     
     
155. ANTONIOS L, Chen W, Dilsizian V
     The Impact of COVID-19 on Nuclear Medicine Operations Including Cardiovascular Manifestations in the USA.
     Semin Nucl Med. 2021 Jun 17. pii: S0001-2998(21)00035.
     PubMed     Abstract available
     
     
     
156. ZAMORA E, Moadel RM, Song N, Zuckier LS, et al
     Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-19.
     Semin Nucl Med. 2021 Jun 17. pii: S0001-2998(21)00037.
     PubMed     Abstract available
     
     
     
157. BOM HH, Pascual TN, Choudhury PS, Al-Ibraheem A, et al
     Impact of COVID-19 on Nuclear Medicine in Asia.
     Semin Nucl Med. 2021 Jun 16. pii: S0001-2998(21)00033.
     PubMed     Abstract available
     
     
     
158. KIKANO EG, Avril S, Marshall H, Jones RS, et al
     PET/CT Variants and Pitfalls in Breast Cancers.
     Semin Nucl Med. 2021 Jun 1. pii: S0001-2998(21)00021.
     PubMed     Abstract available
     
     
     May 2021
159. ARSLAN E, Cermik TF
     PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas.
     Semin Nucl Med. 2021 May 25. pii: S0001-2998(21)00022.
     PubMed     Abstract available
     
     
     
160. SINGH V, Dorbala S
     Normal Variants and Pitfalls in Cardiac PET/CT.
     Semin Nucl Med. 2021 May 25. pii: S0001-2998(21)00020.
     PubMed     Abstract available
     
     
     
161. AFAQ A, Faul D, Chebrolu VV, Wan S, et al
     Pitfalls on PET/MRI.
     Semin Nucl Med. 2021 May 18. pii: S0001-2998(21)00019.
     PubMed     Abstract available
     
     
     
162. LOPCI E, Kobe C, Gnanasegaran G, Adam JA, et al
     "PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma".
     Semin Nucl Med. 2021 May 11. pii: S0001-2998(21)00018.
     PubMed     Abstract available
     
     
     
163. JAYAPRAKASAM VS, Paroder V, Schoder H
     Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.
     Semin Nucl Med. 2021 May 5. pii: S0001-2998(21)00017.
     PubMed     Abstract available
     
     
     
164. MIHAILOVIC J, Killeen RP, Duignan JA
     PET/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer.
     Semin Nucl Med. 2021 May 1. pii: S0001-2998(21)00015.
     PubMed     Abstract available
     
     
     
165. KRISHNADAS N, Villemagne VL, Dore V, Rowe CC, et al
     Advances in Brain Amyloid Imaging.
     Semin Nucl Med. 2021;51:241-252.
     PubMed     Abstract available
     
     
     
166. BEYER L, Brendel M
     Imaging of Tau Pathology in Neurodegenerative Diseases: An Update.
     Semin Nucl Med. 2021;51:253-263.
     PubMed     Abstract available
     
     
     
167. FRANTELLIZZI V, Conte M, De Vincentis G
     Hybrid Imaging of Vascular Cognitive Impairment.
     Semin Nucl Med. 2021;51:286-295.
     PubMed     Abstract available
     
     
     April 2021
168. IMPERIALE A, Meuter L, Pacak K, Taieb D, et al
     Variants and Pitfalls of PET/CT in Neuroendocrine Tumors.
     Semin Nucl Med. 2021 Apr 7. pii: S0001-2998(21)00014.
     PubMed     Abstract available
     
     
     
169. CECCHIN D, Garibotto V, Law I, Goffin K, et al
     PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls.
     Semin Nucl Med. 2021 Apr 3. pii: S0001-2998(21)00016.
     PubMed     Abstract available
     
     
     January 2021
170. JENSEN K, Al-Farra G, Dejanovic D, Eriksen JG, et al
     Imaging for Target Delineation in Head and Neck Cancer Radiotherapy.
     Semin Nucl Med. 2021;51:59-67.
     PubMed     Abstract available
     
     
     
171. SKANJETI A, Dhomps A, Paschetta C, Tordo J, et al
     Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer.
     Semin Nucl Med. 2021;51:39-49.
     PubMed     Abstract available
     
     
     
172. JUNN JC, Soderlund KA, Glastonbury CM
     Imaging of Head and Neck Cancer With CT, MRI, and US.
     Semin Nucl Med. 2021;51:3-12.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.